C4X Discovery Appoints CEO


Sign up online today & collaborate

or click here to find out more

C4X Discovery Appoints CEO


Dr Clive Dix has been appointed chief executive of Manchester-headquartered drug researcher C4X Discovery.

He joined the business as non-executive chairman in October 2014 and became executive chairman in November 2015‎.

Non-executive director Sam Williams will become interim chairman while the search for a new chairman is undertaken.

Dix said: "Having ‎seen from an executive position the potential of the platform to generate entirely new compounds against high-value therapeutic targets more rapidly and efficiently than any technology I've come across before and having witnessed the interest we're receiving in C4X Discovery, I am delighted to take the helm on a full-time basis.

"I have never been more excited by a company than this one." 

Most recently, Dix was chief executive of Convergence Pharmaceuticals, which was sold to Biogen in January 2015 for $675m (£464m).

Prior to that, he was involved in exits with PowderMed, Auralis and PowderJect Pharmaceuticals.

© Catalyst Innovation Portal 2019